Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Nimishetti Naganna"'
Autor:
Caroline W. Karanja, Nimishetti Naganna, Nader S. Abutaleb, Neetu Dayal, Kenneth I. Onyedibe, Uma Aryal, Mohamed N. Seleem, Herman O. Sintim
Publikováno v:
Molecules, Vol 27, Iss 16, p 5085 (2022)
A new class of alkynyl isoquinoline antibacterial compounds, synthesized via Sonogashira coupling, with strong bactericidal activity against a plethora of Gram-positive bacteria including methicillin- and vancomycin-resistant Staphylococcus aureus (S
Externí odkaz:
https://doaj.org/article/c6e05fb522464e4eb21a3521ac1bfb0e
Autor:
Huang, Jian, Zhang, Ting, Kalashova, Julia, Li, Jinhua, Yang, Chenglu, Zhong, Linsheng, Zhou, Xiaohu, Shi, Qiong, Lv, Gang, Chenyu, Jiadai, Abuliezi, Yidan Xia, Yu, Duo, Jiang, Xuejiao, Chenna Reddy, Mallu, Choudhry, Namrta, Nimishetti, Naganna, Yang, Dun
Publikováno v:
In European Journal of Medicinal Chemistry Reports August 2024 11
Autor:
Li, Jinhua, Choudhry, Namrta, Lv, Gang, Nimishetti, Naganna, Reddy, Mallu Chenna, Liu, Hong, Allen, Thaddeus D., Zhang, Jing, Yang, Dun
Publikováno v:
In Journal of Pharmaceutical and Biomedical Analysis 5 August 2023 232
Autor:
Lv, Gang, Shi, Qiong, Zhang, Ting, Li, Jinhua, Long, Yan, Zhang, Wenhui, Choudhry, Namrta, Yang, Kevin, Li, Hongmei, Kalashova, Julia, Yang, Chenglu, Zhou, Xiaohu, Reddy, Mallu Chenna, Anantoju, Kishore Kumar, Zhang, Shenqiu, Zhang, Jing, Allen, Thaddeus D., Liu, Hong, Nimishetti, Naganna, Yang, Dun
Publikováno v:
In Bioorganic & Medicinal Chemistry 15 February 2023 80
Autor:
Lv, Gang, Shi, Qiong, Zhang, Ting, Li, Jinhua, Kalashova, Julia, Long, Yan, Sun, Yin, Li, Chao, Choudhry, Namrta, Li, Hongmei, Yang, Chenglu, Zhou, Xiaohu, Reddy, Mallu Chenna, Anantoju, Kishore Kumar, Jupelli, Rajesh, Zhang, Shenqiu, Zhang, Jing, Allen, Thaddeus, Liu, Hong, Nimishetti, Naganna, Yang, Dun
Publikováno v:
In European Journal of Medicinal Chemistry 5 January 2023 245 Part 1
Autor:
Ujjwol Khatri, Neetu Dayal, Xueqing Hu, Elizabeth Larocque, Nimishetti Naganna, Tao Shen, Xuan Liu, Frederick W. Holtsberg, M. Javad Aman, Herman O. Sintim, Jie Wu
Publikováno v:
Molecular Cancer Therapeutics. :OF1-OF9
Selpercatinib (LOXO292) and pralsetinib (BLU667) are RET protein tyrosine kinase inhibitors (TKIs) recently approved for treating RET-altered cancers. However, RET mutations that confer selpercatinib/pralsetinib resistance have been identified, neces
Autor:
Jie Wu, Herman O. Sintim, M. Javad Aman, Frederick W. Holtsberg, Xuan Liu, Tao Shen, Nimishetti Naganna, Elizabeth Larocque, Xueqing Hu, Neetu Dayal, Ujjwol Khatri
Supplementary information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6266053e960e98dc87d292d8ac0ae3
https://doi.org/10.1158/1535-7163.22651725
https://doi.org/10.1158/1535-7163.22651725
Autor:
Jie Wu, Herman O. Sintim, M. Javad Aman, Frederick W. Holtsberg, Xuan Liu, Tao Shen, Nimishetti Naganna, Elizabeth Larocque, Xueqing Hu, Neetu Dayal, Ujjwol Khatri
Selpercatinib (LOXO292) and pralsetinib (BLU667) are RET protein tyrosine kinase inhibitors (TKIs) recently approved for treating RET-altered cancers. However, RET mutations that confer selpercatinib/pralsetinib resistance have been identified, neces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4100742c57f1d7f5fbdd04bfd2365562
https://doi.org/10.1158/1535-7163.c.6604950
https://doi.org/10.1158/1535-7163.c.6604950
Autor:
Caroline W. Karanja, Nimishetti Naganna, Nader S. Abutaleb, Neetu Dayal, Kenneth I. Onyedibe, Uma Aryal, Mohamed N. Seleem, Herman O. Sintim
Publikováno v:
Molecules; Volume 27; Issue 16; Pages: 5085
A new class of alkynyl isoquinoline antibacterial compounds, synthesized via Sonogashira coupling, with strong bactericidal activity against a plethora of Gram-positive bacteria including methicillin- and vancomycin-resistant Staphylococcus aureus (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7370df1be4cc4119fef30932f451b789
https://hdl.handle.net/10919/111512
https://hdl.handle.net/10919/111512
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.